Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Diluted Average) (2019 - 2025)

Collegium Pharmaceutical (COLL) has 5 years of Shares Outstanding (Diluted Average) data on record, last reported at $39.4 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) fell 1.8% year-over-year to $39.4 million; the TTM value through Sep 2025 reached $39.4 million, down 1.8%, while the annual FY2024 figure was $40.4 million, 3.26% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $39.4 million in Q3 2025 per COLL's latest filing, up from $39.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $41.8 million in Q4 2023 and bottomed at $32.8 million in Q1 2025.
  • Average Shares Outstanding (Diluted Average) over 3 years is $39.4 million, with a median of $40.3 million recorded in 2024.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 1.8% in 2025, down 20.75% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $41.8 million in 2023, then decreased by 3.26% to $40.4 million in 2024, then fell by 2.43% to $39.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $39.4 million in Q3 2025, $39.1 million in Q2 2025, and $32.8 million in Q1 2025.